Kevin Strauss to Mechanistic Target of Rapamycin Complex 1
This is a "connection" page, showing publications Kevin Strauss has written about Mechanistic Target of Rapamycin Complex 1.
Connection Strength
0.069
-
Parker WE, Orlova KA, Parker WH, Birnbaum JF, Krymskaya VP, Goncharov DA, Baybis M, Helfferich J, Okochi K, Strauss KA, Crino PB. Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder. Sci Transl Med. 2013 Apr 24; 5(182):182ra53.
Score: 0.026
-
Orlova KA, Tsai V, Baybis M, Heuer GG, Sisodiya S, Thom M, Strauss K, Aronica E, Storm PB, Crino PB. Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias. J Neuropathol Exp Neurol. 2010 Aug; 69(8):850-63.
Score: 0.022
-
Orlova KA, Parker WE, Heuer GG, Tsai V, Yoon J, Baybis M, Fenning RS, Strauss K, Crino PB. STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice. J Clin Invest. 2010 May; 120(5):1591-602.
Score: 0.021